Equity

Unrealized Gains on Investments

Over 5 years (FY 2020 to FY 2025), Unrealized Gains on Investments shows a downward trend with a -100.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionEquity
First reportedQ2 2018
Last reportedQ1 2026Apr 30, 2026
Metric ID: unrealized_gains_on_investments

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.00M$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
QoQ Change-100.0%
YoY Change-100.0%
Range$0.00$1.00M
CAGR-100.0%
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Unrealized Gains on Investments at Other Companies

Frequently Asked Questions

What is Amgen's unrealized gains on investments?
Amgen (AMGN) reported unrealized gains on investments of $0.00 in Q1 2026.
What is the long-term trend for Amgen's unrealized gains on investments?
Over 5 years (2020 to 2025), Amgen's unrealized gains on investments has grown at a -100.0% compound annual growth rate (CAGR), from $1.00M to $0.00.